MEDICLINIC INTERNATIONAL LIMITED - Granting and acceptance of share awards by directors and the company secretary of Mediclinic

Granting and acceptance of share awards by directors and the company secretary of Mediclinic

Mediclinic International Limited
Incorporated in the Republic of South Africa
Reg. no. 1983/010725/06
Income tax no: 9950122714
JSE Share code: MDC
NSX share code: MCI
ISIN code: ZAE000074142
(“Mediclinic” or “the Company”)

GRANTING AND ACCEPTANCE OF SHARE AWARDS BY DIRECTORS AND THE
COMPANY SECRETARY OF MEDICLINIC

In compliance with the JSE Limited Listings Requirements, the
following executive directors and the company secretary of
Mediclinic have been granted and have accepted forfeitable or
conditional share awards, as indicated below, in terms of the
Mediclinic Forfeitable Share Plan, as approved by the Company’s
shareholders at the annual general meeting in July 2014. Subject
to meeting certain prescribed performance conditions, vesting will
occur on the later of 31 May 2018 or the date upon which the
Company’s Remuneration Committee is satisfied that the performance
conditions have been satisfied.

Director                     :   D P Meintjes
Company                      :   Mediclinic International Limited
Date of acceptance           :   17 June 2015
Nature of transaction        :   Off-market acceptance of
                                 forfeitable share awards.
Number of securities         :   69 639
Class of securities          :   Ordinary shares
Consideration payable        :   Nil
Total value of transaction   :   R6 894 261.00 based on the
on acceptance                    closing price of R99.00 per
                                 share on 15 June 2015.
Nature of interest           :   Direct beneficial
Clearance obtained           :   Yes

Director                     :   C I Tingle
Company                      :   Mediclinic International Limited
Date of acceptance           :   17 June 2015
Nature of transaction        :   Off-market acceptance of
                                 forfeitable share awards.
Number of securities         :   40 649
Class of securities          :   Ordinary shares
Consideration payable        :   Nil
Total value of transaction   :   R4 024 251.00 based on the
on acceptance                    closing price of R99.00 per
                                 share on 15 June 2015.
Nature of interest           :   Direct beneficial
Clearance obtained           :   Yes

Director                     :   K H S Pretorius
Company                      :   Mediclinic International Limited
Date of acceptance           :   17 June 2015
Nature of transaction        :   Off-market acceptance of
                                 forfeitable share awards.
Number of securities         :   27 160
Class of securities          :   Ordinary shares
Consideration payable        :   Nil
Total value of transaction   :   R2 688 840.00 based on the
on acceptance                    closing price of R99.00 per
                                 share on 15 June 2015.
Nature of interest           :   Direct beneficial
Clearance obtained           :   Yes

Director                     :   T O Wiesinger
Company                      :   Mediclinic International Limited
Date of acceptance           :   17 June 2015
Nature of transaction        :   Off-market acceptance of
                                 conditional share awards.
Number of securities         :   24 936
Class of securities          :   Ordinary shares
Consideration payable        :   Nil
Total value of transaction   :   R2 468 664.00 based on the
on acceptance                    closing price of R99.00 per
                                 share on 15 June 2015.
Nature of interest           :   Direct beneficial
Clearance obtained           :   Yes

Director                     :   C A van der Merwe
Company                      :   Mediclinic International Limited
Date of acceptance           :   17 June 2015
Nature of transaction        :   Off-market acceptance of
                                 forfeitable share awards.
Number of securities         :   23 034
Class of securities          :   Ordinary shares
Consideration payable        :   Nil
Total value of transaction   :   R2 280 366.00 based on the
on acceptance                    closing price of R99.00 per
                                 share on 15 June 2015.
Nature of interest           :   Direct beneficial
Clearance obtained           :   Yes

Director                     :   G C Hattingh (Company Secretary)
Company                      :   Mediclinic International Limited
Date of acceptance           :   17 June 2015
Nature of transaction        :   Off-market acceptance of
                                 forfeitable share awards.
Number of securities         :   20 705
Class of securities          :   Ordinary shares
Consideration payable        :   Nil
Total value of transaction   :   R2 049 795.00 based on the
on acceptance                    closing price of R99.00 per
                                 share on 15 June 2015.
Nature of interest           :   Direct beneficial
Clearance obtained           :   Yes

Stellenbosch
18 June 2015

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316 (if dialling from South Africa) or
ethics@mediclinic.com
Website: www.mediclinic.com

Sponsor
South Africa: RAND MERCHANT BANK (A division of FirstRand Bank
Limited)
Namibia: Simonis Storm Securities (Proprietary) Limited

Date: 18/06/2015 04:52:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.